Skip to main content
Clinical Trials/NCT06076408
NCT06076408
Completed
Not Applicable

Effects of Sustained Natural Apophyseal Glides With and Without Pilates on Pain, Range of Motion and Disability in Patients With Lumbar Disc Bulge

Riphah International University1 site in 1 country44 target enrollmentOctober 3, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lumbar Disc Herniation
Sponsor
Riphah International University
Enrollment
44
Locations
1
Primary Endpoint
Lumbar ROM by inclinometer
Status
Completed
Last Updated
last year

Overview

Brief Summary

The aim of this study is to compare the effects of Sustained Natural Apophyseal Glides with and without Pilates on pain, range of motion and disability in patients with lumbar Disc Bulge.

Detailed Description

Lumbar disc disease may occur when a disc in the low back area of the spine bulges or herniates between the bony areas of the spine. Lumbar disk disease causes lower back pain and leg pain and weakness that is made worse by movement and activity. Lumbar disc bulge is typically managed through a multidimensional approach that integrates various therapeutic techniques aimed at reducing symptoms and enhancing functional outcomes. The use of SNAGs has been shown to produce positive results such as decreased pain levels and increased mobility in previous studies. Overall physical conditioning can be improved by using a holistic approach that consists of controlled movements combined with breathing techniques and mindfulness. In order to treat lumbar disc bulge patients more effectively, it is important to understand how use and efficacy differ when applying SNAGs alone versus together with Pilates. Delving into how combining SNAGs and Pilates affects lumbar disc bulge patients contributes to an expanding body of proof advocating for a multimodal treatment.

Registry
clinicaltrials.gov
Start Date
October 3, 2023
End Date
April 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient of both gender under the age of 40-60 year.
  • Unilateral radiating pain through the course of sciatic nerve
  • a duration of pain of at least 3 months
  • Restricted lumbar range of motion.
  • Subjects who can understand the instructions and are willing to participate in the study
  • Positive slump test with positive pain location and positive pain descriptors.
  • Passive Lumbar Extension If the patient experiences severe low back pain or if there is a feeling of heaviness on the lower back or a feeling as though the lower back were about to 'come off' the test is considered positive.
  • Straight Leg Raise SLR test positive when it evokes radiating pain along the course of the sciatic nerve and below the knee between 30 and 70 degrees of hip flexion

Exclusion Criteria

  • History of trauma, dislocation and subluxation of lower extremity.
  • Rheumatoid Arthritis
  • Systemic diseases such as blood coagulation disorders, chronic pain syndrome, cancer, allergies fibromyalgia, systemic lupus erythematous, and psoriatic arthritis.
  • Lumbar spine surgery patients.
  • Malignancy
  • neurologic disorders (e.g., trigeminal neuralgia or occipital neuralgia)
  • clinical diagnosis of lumbar bilateral radiculopathy or myelopathy
  • history of previous physical therapy intervention for the lumbar region in last 6 months

Outcomes

Primary Outcomes

Lumbar ROM by inclinometer

Time Frame: 3 weeks

Inclinometer is used to measure the range of motion on Lumbar spine. "Change in ROM will be measured from baseline to 3 weeks".

Numeric Pain Rating Scale (NPRS)

Time Frame: 3 weeks

NPRS scale can be used to quantify pain intensity levels. The 11-point scale ranges from '0' for the least amount of pain "no pain" to '10' for the most extreme levels of pain "pain as severe as you can imagine". It is convenient to use NPRS for patients. Its score ranges between 0-10. "change will be measured from baseline to 3 weeks"

Modified Oswestry Disability Index

Time Frame: 3 weeks

The ODI is a disease specific disability measure is used to establish measure a level of disability stage of patients' acuity status and monitor change over time. The final score ranges from 0-100. A score of 0-20 reflects minimal disability, 21-40 moderate disability, 41-60 severe disability, 61-80 crippled, and 81-100 bed-bound. "Change will be measured from baseline to 3 weeks"

Study Sites (1)

Loading locations...

Similar Trials